Evidence map›Paper›PMID 35479845›Full record

ArticleExploratory research in clinical and social pharmacy2021

Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia.

Grace Trull, Erin Major, Chase Harless, William Zule, Bayla Ostrach, Delesha Carpenter

Abstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Assessing suboxone access in community pharmacies: Secret shopper model.Exploratory research in clinical and social pharmacy · 2023
    Article
  6. Article
  7. Article
  8. Factors in rural community buprenorphine dispensing.Exploratory research in clinical and social pharmacy · 2023
    Article
  9. Article
  10. A content review of buprenorphine training programs for pharmacists.Exploratory research in clinical and social pharmacy · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Grace TrullUniversity of North Carolina at Chapel Hill, Eshelman School of Pharmacy, 301 Pharmacy Lane, CB#7355, Chapel Hill, NC 27599, USA.
Erin MajorUNC Health Sciences at Mountain Area Health Education Center, 121 Henderson Road, Asheville, NC 28803, USA.
Chase HarlessUNC Health Sciences at Mountain Area Health Education Center, 121 Henderson Road, Asheville, NC 28803, USA.
William ZuleResearch Triangle Institute International, 3040 East Cornwallis Road, Research Triangle Park, NC 27709, USA.
Bayla OstrachBoston University, School of Medicine, 72 East Concord St, Boston, MA 02118, USA.
Delesha CarpenterUniversity of North Carolina at Chapel Hill, Eshelman School of Pharmacy, 1 University Heights, CPO 2125, Asheville, NC 28804, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Buprenorphine access is limited for patients with opioid use disorder, especially in rural areas. Telephone audits have identified pharmacist limitations to the dispensing of buprenorphine particularly in independent pharmacies in comparison to chain pharmacies and in rural areas. The objective of this study was to assess rural community pharmacists' stated willingness to dispense buprenorphine-naloxone, and document potential bias and or stigma that the shopper experiences when asking about buprenorphine- naloxone. Methods: To assess pharmacist willingness, a telephone audit of 15 rural Appalachian North Carolina pharmacies was conducted. Three secret shopper scenarios were utilized including one shopper posing as a new patient, one shopper posing as an out of state patient, and one shopper first asking about buying syringes. Encounters were noted by willingness to dispense buprenorphine, and shoppers were to note any potential stigma and or bias that they experienced while asking for Suboxone®. Results: Overall, 60% of pharmacies audited indicated willingness to dispense buprenorphine without reservation, and 31% indicated willingness to dispense only under certain circumstances. Pharmacies tended to add more conditions to dispensing to the out of state patient (46%), such as only dispensing if the practitioner was from in state in comparison to the other shopper scenarios. Potential stigma and bias were encountered in 40% of the 45 encounters. Conclusion: Although pharmacies overall seemed willing to dispense, nuances regarding who pharmacies are most likely to dispense are felt in rural areas. Buprenorphine access limitations were more common in independent pharmacies and more often placed on patients from out of state. Pharmacy- directed education is necessary to reduce stigma and bias and increase patient access to buprenorphine.

Indexed as

AccessBuprenorphineOpioid use disorderPharmacistRural

Identifiers

PMID35479845
PMCPMC9031434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.